These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1765651)

  • 1. Detection of antibody to the PreS2 sequence of the hepatitis B virus envelope protein using an immuno-ligand assay with a silicon sensor detection system.
    Hurni WM; Miller WJ; Zuk RF; Kung VT
    J Immunol Methods; 1991 Dec; 145(1-2):19-26. PubMed ID: 1765651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2 + S vaccine.
    Hurni WM; Roehm RR; Miller WJ
    J Med Virol; 1990 Feb; 30(2):146-50. PubMed ID: 2313274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IgM, IgA, and IgG antibodies to preS2 antigen in hepatitis B virus infection.
    Suga M; Arima K; Yachi A
    Digestion; 1991; 50(3-4):153-61. PubMed ID: 1812042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope.
    Park JH; Lee MK; Kim HS; Kim KL; Cho EW
    J Viral Hepat; 2003 Jan; 10(1):70-9. PubMed ID: 12558915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
    Jing M; Wang J; Zhu S; Ao F; Wang L; Han T; Yue X; Zhu Y; Ye L; Liu S
    Vaccine; 2016 Jan; 34(4):516-522. PubMed ID: 26686999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein.
    Emini EA; Larson V; Eichberg J; Conard P; Garsky VM; Lee DR; Ellis RW; Miller WJ; Anderson CA; Gerety RJ
    J Med Virol; 1989 May; 28(1):7-12. PubMed ID: 2723618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.
    Cupps TR; Hoofnagle JH; Ellis RW; Miller WJ; Gerin JL; Volkman DJ; Haas-Smith SA
    J Infect Dis; 1990 Mar; 161(3):412-9. PubMed ID: 2313122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection.
    Guo M; Kang B; Zheng Q; Qian Q; Su C; Wu M; Yang J
    Acta Gastroenterol Belg; 2009; 72(3):306-11. PubMed ID: 19902863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.
    Clements ML; Miskovsky E; Davidson M; Cupps T; Kumwenda N; Sandman LA; West D; Hesley T; Ioli V; Miller W
    J Infect Dis; 1994 Sep; 170(3):510-6. PubMed ID: 8077707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.
    Cupps TR; Tibbles J; Hurni WM; Miller WJ; Ellis RW; Milich D; Wetter N
    J Immunol; 1993 Sep; 151(6):3353-60. PubMed ID: 7690803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine.
    Pillot J; Poynard T; Elias A; Maillard J; Lazizi Y; Brancer M; Dubreuil P; Budkowska A; Chaput JC
    Vaccine; 1995 Feb; 13(3):289-94. PubMed ID: 7631515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of immunofiltration assay by light addressable potentiometric sensor with genetically biotinylated recombinant antibody for rapid identification of Venezuelan equine encephalitis virus.
    Hu WG; Thompson HG; Alvi AZ; Nagata LP; Suresh MR; Fulton RE
    J Immunol Methods; 2004 Jun; 289(1-2):27-35. PubMed ID: 15251409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A silicon sensor-based filtration immunoassay using biotin-mediated capture.
    Olson JD; Panfili PR; Armenta R; Femmel MB; Merrick H; Gumperz J; Goltz M; Zuk RF
    J Immunol Methods; 1990 Nov; 134(1):71-9. PubMed ID: 2230151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid immunofiltration assay of Newcastle disease virus using a silicon sensor.
    Lee WE; Thompson HG; Hall JG; Fulton RE; Wong JP
    J Immunol Methods; 1993 Nov; 166(1):123-31. PubMed ID: 8228283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
    Sobotta D; Sominskaya I; Jansons J; Meisel H; Schmitt S; Heermann KH; Kaluza G; Pumpens P; Gerlich WH
    J Gen Virol; 2000 Feb; 81(Pt 2):369-78. PubMed ID: 10644835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice.
    Youm JW; Won YS; Jeon JH; Ryu CJ; Choi YK; Kim HC; Kim BD; Joung H; Kim HS
    Vaccine; 2007 Jan; 25(3):577-84. PubMed ID: 16945456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.